+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Stretch Marks Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 250 Pages
  • December 2023
  • Region: Global
  • Fairfield Market Research
  • ID: 5913362
The global Stretch Marks Treatment Market has experienced substantial growth, reaching a valuation of US$ 2.8 billion in 2024 and is projected to reach US$ 4.4 billion by the end of 2031. This impressive growth can be attributed to factors such as increasing concerns about skin aesthetics, technological advancements, and the rising demand for less invasive treatment options.

Key Trends Shaping the Stretch Marks Treatment Market

Increasing Demand for Less Painful Treatment Options (Laser Treatment)

The market is witnessing a surge in demand for less invasive and more comfortable stretch mark treatment options. Technological advancements have introduced solutions like chemical peels, laser-based technology, and micro abrasion techniques. Consumers are increasingly opting for these procedures due to their minimal invasiveness and enhanced comfort. Laser technology, in particular, has seen significant developments, offering multiple choices to consumers. Regulatory approvals for these treatments have boosted consumer confidence, further driving demand.

High Cost of Treatment Denting Market Expansion

Despite the promising growth, the high cost of aesthetic, minimally invasive treatments like CO2 lasers and microdermabrasion is hindering market expansion. The cost of stretch mark treatment can vary significantly based on factors such as the severity of stretch marks, patient willingness, location of stretch marks on the body, and the quantity of product used. This cost variability, coupled with the scarcity of trained professionals, has led some individuals to explore alternative options.

Country-wise Insights

Why is the United States a Lucrative Market for Stretch Marks Treatment?

The United States is a thriving market for stretch marks treatment, driven by the increasing acceptance of aesthetic cosmetic procedures. People of all age groups are motivated to enhance their physical appearance, leading to a surge in demand for procedures such as total ablative and non-ablative skin resurfacing, chemical peeling, and more. Stretch marks are a common concern, affecting pregnant women and 80% of teenagers in the United States. The growing population of adolescents is expected to further boost demand.

Will Germany Be a Lucrative Market for Stretch Marks Treatment?

Germany shows promise as a lucrative market due to the rising prevalence of obesity. With over half of its population classified as overweight, people in Germany are increasingly turning to aesthetic procedures and topical options to improve their appearance. The availability of a wide range of treatment options, including laser treatments, contributes to the high adoption rate. Additionally, the country's high disposable income allows households to invest in cosmetic procedures.

How is China Emerging as a Prominent Market for Stretch Marks Treatment?

China's beauty standards are driving significant demand for skin treatments, particularly for scar and stretch mark concealment. Influenced by social media, there is a strong desire for flawless skin and adherence to beauty standards. Minimally invasive procedures, including laser treatments, are gaining popularity in China, contributing to the market's growth.

Competitive Landscape

Leading market players are actively developing unique formulations that promise improved stretch mark reduction and competitive pricing. Capacity expansion and product launches are among the consolidation efforts undertaken by several market players in the stretch marks treatment sector. Key companies profiled in this market include,
  • Weleda
  • Clarins
  • basq NYC
  • Body Merry
  • Himalaya Global Holdings Ltd.
  • Stratpharma AG (Stratpharma Inc.)
  • Browne Drug Co., Inc. (Palmer’s)
  • Mederma (HRA Pharma)
  • Givaudan SA
  • NEOSTRATA COMPANY, INC. (Johnson & Johnson Services, Inc.)
  • Bio-Oil (Union Swiss (Pty) Ltd)
  • Merz Pharma
  • Dermaclara
  • Unilever

Key Segments of Stretch Marks Treatment Industry Research

By Treatment:

  • Topical Medications
  • Gels
  • Creams
  • Oils/Serums
  • Procedural Treatments
  • Radiofrequency Therapy
  • Non-ablative Laser Fractional Resurfacing
  • Ablative Laser Resurfacing
  • Infrared Devices/Radiations
  • Dermabrasion
  • Chemical Peels

By Stretch Mark Type:

  • Striae atrophicans (Thinned Skin)
  • Striae gravidarum (Post Pregnancy)
  • Striae distensae (Stretched Skin)
  • striae rubrae (Red)
  • Striae albae (White)
  • Striae nigra (Black)
  • Striae caerulea (Dark Blue)

By End User:

  • Hospitals
  • Dermatology Clinics
  • Aesthetic Clinics
  • Wellness and Spa Centers
  • Home Care Settings

By Region:

  • North America
  • Latin America
  • Europe Stretch
  • South Asia Stretch
  • East Asia Stretch
  • Oceania Stretch
  • The Middle East & Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Stretch Marks Treatment Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Stretch Marks Treatment Market Outlook, 2018 - 2031
3.1. Global Stretch Marks Treatment Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Topical Medications
3.1.1.1.1. Gels
3.1.1.1.2. Creams
3.1.1.1.3. Oils/Serums
3.1.1.2. Procedural Treatments
3.1.1.2.1. Radiofrequency Therapy
3.1.1.2.2. Non-ablative Laser Fractional Resurfacing
3.1.1.2.3. Ablative Laser Resurfacing
3.1.1.2.4. Infrared Devices/Radiations
3.1.1.2.5. Dermabrasion
3.1.1.2.6. Chemical Peels
3.2. Global Stretch Marks Treatment Market Outlook, by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Striae atrophicans (Thinned Skin)
3.2.1.2. Striae gravidarum (Post Pregnancy)
3.2.1.3. Striae distensae (Stretched Skin)
3.2.1.4. striae rubrae (Red)
3.2.1.5. Striae albae (White)
3.2.1.6. Striae nigra (Black)
3.2.1.7. Striae caerulea (Dark Blue)
3.3. Global Stretch Marks Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Hospitals
3.3.1.2. Dermatology Clinics
3.3.1.3. Aesthetic Clinics
3.3.1.4. Wellness and Spa Centers
3.3.1.5. Home Care Settings
3.4. Global Stretch Marks Treatment Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Stretch Marks Treatment Market Outlook, 2018 - 2031
4.1. North America Stretch Marks Treatment Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Topical Medications
4.1.1.1.1. Gels
4.1.1.1.2. Creams
4.1.1.1.3. Oils/Serums
4.1.1.2. Procedural Treatments
4.1.1.2.1. Radiofrequency Therapy
4.1.1.2.2. Non-ablative Laser Fractional Resurfacing
4.1.1.2.3. Ablative Laser Resurfacing
4.1.1.2.4. Infrared Devices/Radiations
4.1.1.2.5. Dermabrasion
4.1.1.2.6. Chemical Peels
4.2. North America Stretch Marks Treatment Market Outlook, by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Striae atrophicans (Thinned Skin)
4.2.1.2. Striae gravidarum (Post Pregnancy)
4.2.1.3. Striae distensae (Stretched Skin)
4.2.1.4. striae rubrae (Red)
4.2.1.5. Striae albae (White)
4.2.1.6. Striae nigra (Black)
4.2.1.7. Striae caerulea (Dark Blue)
4.3. North America Stretch Marks Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Hospitals
4.3.1.2. Dermatology Clinics
4.3.1.3. Aesthetic Clinics
4.3.1.4. Wellness and Spa Centers
4.3.1.5. Home Care Settings
4.4. North America Stretch Marks Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
4.4.1.2. U.S. Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
4.4.1.3. U.S. Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
4.4.1.4. Canada Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
4.4.1.5. Canada Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
4.4.1.6. Canada Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Stretch Marks Treatment Market Outlook, 2018 - 2031
5.1. Europe Stretch Marks Treatment Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Topical Medications
5.1.1.1.1. Gels
5.1.1.1.2. Creams
5.1.1.1.3. Oils/Serums
5.1.1.2. Procedural Treatments
5.1.1.2.1. Radiofrequency Therapy
5.1.1.2.2. Non-ablative Laser Fractional Resurfacing
5.1.1.2.3. Ablative Laser Resurfacing
5.1.1.2.4. Infrared Devices/Radiations
5.1.1.2.5. Dermabrasion
5.1.1.2.6. Chemical Peels
5.2. Europe Stretch Marks Treatment Market Outlook, by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Striae atrophicans (Thinned Skin)
5.2.1.2. Striae gravidarum (Post Pregnancy)
5.2.1.3. Striae distensae (Stretched Skin)
5.2.1.4. striae rubrae (Red)
5.2.1.5. Striae albae (White)
5.2.1.6. Striae nigra (Black)
5.2.1.7. Striae caerulea (Dark Blue)
5.3. Europe Stretch Marks Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Dermatology Clinics
5.3.1.3. Aesthetic Clinics
5.3.1.4. Wellness and Spa Centers
5.3.1.5. Home Care Settings
5.4. Europe Stretch Marks Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Germany Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
5.4.1.2. Germany Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
5.4.1.3. Germany Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.4. U.K. Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
5.4.1.5. U.K. Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
5.4.1.6. U.K. Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.7. France Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
5.4.1.8. France Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
5.4.1.9. France Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.10. Italy Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
5.4.1.11. Italy Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
5.4.1.12. Italy Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.13. Turkey Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
5.4.1.14. Turkey Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
5.4.1.15. Turkey Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.16. Russia Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
5.4.1.17. Russia Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
5.4.1.18. Russia Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.19. Rest of Europe Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
5.4.1.20. Rest of Europe Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
5.4.1.21. Rest of Europe Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Stretch Marks Treatment Market Outlook, 2018 - 2031
6.1. Asia Pacific Stretch Marks Treatment Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Topical Medications
6.1.1.1.1. Gels
6.1.1.1.2. Creams
6.1.1.1.3. Oils/Serums
6.1.1.2. Procedural Treatments
6.1.1.2.1. Radiofrequency Therapy
6.1.1.2.2. Non-ablative Laser Fractional Resurfacing
6.1.1.2.3. Ablative Laser Resurfacing
6.1.1.2.4. Infrared Devices/Radiations
6.1.1.2.5. Dermabrasion
6.1.1.2.6. Chemical Peels
6.2. Asia Pacific Stretch Marks Treatment Market Outlook, by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Striae atrophicans (Thinned Skin)
6.2.1.2. Striae gravidarum (Post Pregnancy)
6.2.1.3. Striae distensae (Stretched Skin)
6.2.1.4. striae rubrae (Red)
6.2.1.5. Striae albae (White)
6.2.1.6. Striae nigra (Black)
6.2.1.7. Striae caerulea (Dark Blue)
6.3. Asia Pacific Stretch Marks Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Dermatology Clinics
6.3.1.3. Aesthetic Clinics
6.3.1.4. Wellness and Spa Centers
6.3.1.5. Home Care Settings
6.4. Asia Pacific Stretch Marks Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. China Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
6.4.1.2. China Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
6.4.1.3. China Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.4. Japan Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
6.4.1.5. Japan Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
6.4.1.6. Japan Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.7. South Korea Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
6.4.1.8. South Korea Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
6.4.1.9. South Korea Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.10. India Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
6.4.1.11. India Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
6.4.1.12. India Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.13. Southeast Asia Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
6.4.1.14. Southeast Asia Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
6.4.1.15. Southeast Asia Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.16. Rest of Asia Pacific Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
6.4.1.17. Rest of Asia Pacific Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
6.4.1.18. Rest of Asia Pacific Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Stretch Marks Treatment Market Outlook, 2018 - 2031
7.1. Latin America Stretch Marks Treatment Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Topical Medications
7.1.1.1.1. Gels
7.1.1.1.2. Creams
7.1.1.1.3. Oils/Serums
7.1.1.2. Procedural Treatments
7.1.1.2.1. Radiofrequency Therapy
7.1.1.2.2. Non-ablative Laser Fractional Resurfacing
7.1.1.2.3. Ablative Laser Resurfacing
7.1.1.2.4. Infrared Devices/Radiations
7.1.1.2.5. Dermabrasion
7.1.1.2.6. Chemical Peels
7.2. Latin America Stretch Marks Treatment Market Outlook, by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
7.2.1.1. Striae atrophicans (Thinned Skin)
7.2.1.2. Striae gravidarum (Post Pregnancy)
7.2.1.3. Striae distensae (Stretched Skin)
7.2.1.4. striae rubrae (Red)
7.2.1.5. Striae albae (White)
7.2.1.6. Striae nigra (Black)
7.2.1.7. Striae caerulea (Dark Blue)
7.3. Latin America Stretch Marks Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Dermatology Clinics
7.3.1.3. Aesthetic Clinics
7.3.1.4. Wellness and Spa Centers
7.3.1.5. Home Care Settings
7.4. Latin America Stretch Marks Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
7.4.1.2. Brazil Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
7.4.1.3. Brazil Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
7.4.1.4. Mexico Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
7.4.1.5. Mexico Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
7.4.1.6. Mexico Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
7.4.1.7. Argentina Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
7.4.1.8. Argentina Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
7.4.1.9. Argentina Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
7.4.1.10. Rest of Latin America Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
7.4.1.11. Rest of Latin America Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
7.4.1.12. Rest of Latin America Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Stretch Marks Treatment Market Outlook, 2018 - 2031
8.1. Middle East & Africa Stretch Marks Treatment Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Topical Medications
8.1.1.1.1. Gels
8.1.1.1.2. Creams
8.1.1.1.3. Oils/Serums
8.1.1.2. Procedural Treatments
8.1.1.2.1. Radiofrequency Therapy
8.1.1.2.2. Non-ablative Laser Fractional Resurfacing
8.1.1.2.3. Ablative Laser Resurfacing
8.1.1.2.4. Infrared Devices/Radiations
8.1.1.2.5. Dermabrasion
8.1.1.2.6. Chemical Peels
8.2. Middle East & Africa Stretch Marks Treatment Market Outlook, by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Striae atrophicans (Thinned Skin)
8.2.1.2. Striae gravidarum (Post Pregnancy)
8.2.1.3. Striae distensae (Stretched Skin)
8.2.1.4. striae rubrae (Red)
8.2.1.5. Striae albae (White)
8.2.1.6. Striae nigra (Black)
8.2.1.7. Striae caerulea (Dark Blue)
8.3. Middle East & Africa Stretch Marks Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Dermatology Clinics
8.3.1.3. Aesthetic Clinics
8.3.1.4. Wellness and Spa Centers
8.3.1.5. Home Care Settings
8.4. Middle East & Africa Stretch Marks Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. GCC Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
8.4.1.2. GCC Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
8.4.1.3. GCC Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.4. South Africa Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
8.4.1.5. South Africa Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
8.4.1.6. South Africa Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.7. Egypt Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
8.4.1.8. Egypt Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
8.4.1.9. Egypt Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.10. Nigeria Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
8.4.1.11. Nigeria Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
8.4.1.12. Nigeria Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.13. Rest of Middle East & Africa Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
8.4.1.14. Rest of Middle East & Africa Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
8.4.1.15. Rest of Middle East & Africa Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Treatment vs Stretch Mark Type Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Weleda
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Clarins
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. basq NYC
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Body Merry
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Himalaya Global Holdings Ltd.
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Stratpharma AG (Stratpharma Inc.)
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Browne Drug Co., Inc. (Palmer’s)
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Mederma (HRA Pharma)
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Givaudan SA
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. NEOSTRATA COMPANY, INC. (Johnson & Johnson Services, Inc.)
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. Merz Pharma
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
9.4.12. Unilever
9.4.12.1. Company Overview
9.4.12.2. Product Portfolio
9.4.12.3. Financial Overview
9.4.12.4. Business Strategies and Development
9.4.13. Bio-Oil (Union Swiss (Pty) Ltd)
9.4.13.1. Company Overview
9.4.13.2. Product Portfolio
9.4.13.3. Financial Overview
9.4.13.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Weleda
  • Clarins
  • basq NYC
  • Body Merry
  • Himalaya Global Holdings Ltd.
  • Stratpharma AG (Stratpharma Inc.)
  • Browne Drug Co., Inc. (Palmer’s)
  • Mederma (HRA Pharma)
  • Givaudan SA
  • NEOSTRATA COMPANY, INC. (Johnson & Johnson Services, Inc.)
  • Bio-Oil (Union Swiss (Pty) Ltd)
  • Merz Pharma
  • Dermaclara
  • Unilever

Methodology

Loading
LOADING...